Boehringer Ingelheim rebrands CMO unit; Vetter prepares for increased demand for filling services;

 @NesaNFierce: Not shocked that the Philippines and Indonesia are eyed as emerging leaders in outsourcing. Population means a lot. More | Follow @NesaNFierce

> German pharmaceutical company Boehringer Ingelheim is rebranding its CMO unit as BioXcellence. More

> Roowin, a French CRO, has moved its operations to the French town of Riom. Release

> Pharm-Olam has signed a multiyear, multimillion-dollar contract to use the Datatrak One software solution for supporting Phase I through Phase IV drug and devices studies in multiple languages throughout the world. Release

> With filling services on the rise for CMOs, Vetter has prepared itself for the trend, announcing that it will build a "state-of-the-art, high-performance" filling line for syringes at its Ravensburg Vetter South location in Germany. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.